Loretta D’Onofrio

698 total citations
18 papers, 299 citations indexed

About

Loretta D’Onofrio is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Loretta D’Onofrio has authored 18 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Loretta D’Onofrio's work include HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers) and Advanced Breast Cancer Therapies (3 papers). Loretta D’Onofrio is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Cancer Treatment and Pharmacology (4 papers) and Advanced Breast Cancer Therapies (3 papers). Loretta D’Onofrio collaborates with scholars based in Italy, United States and Malaysia. Loretta D’Onofrio's co-authors include Giuseppe Tonini, Bruno Vincenzi, Daniele Santini, Chiara Spoto, Emanuela Dell’Aquila, Aldo Pezzuto, Giuseppe Bronte, Gennaro Daniele, Francesco Perrone and Francesca Comito and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Loretta D’Onofrio

15 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Loretta D’Onofrio Italy 8 137 93 80 77 60 18 299
Wan Ling Tan Singapore 8 149 1.1× 144 1.5× 152 1.9× 92 1.2× 79 1.3× 22 407
Aya El Helali Hong Kong 9 108 0.8× 69 0.7× 59 0.7× 53 0.7× 94 1.6× 34 288
Joseph Tang United Kingdom 8 177 1.3× 134 1.4× 48 0.6× 64 0.8× 54 0.9× 14 322
Yunwei Han China 11 135 1.0× 65 0.7× 70 0.9× 103 1.3× 79 1.3× 28 331
Shumei Jiang China 12 162 1.2× 42 0.5× 64 0.8× 92 1.2× 95 1.6× 29 333
Nikoletta Sidiropoulos United States 8 163 1.2× 51 0.5× 114 1.4× 135 1.8× 76 1.3× 21 336
Dezuo Dong China 9 122 0.9× 60 0.6× 77 1.0× 56 0.7× 119 2.0× 20 283
Giulia Rovesti Italy 11 162 1.2× 88 0.9× 50 0.6× 85 1.1× 123 2.0× 27 393
W. Brückl Germany 10 198 1.4× 53 0.6× 163 2.0× 45 0.6× 52 0.9× 27 329
Kunli Zhu China 13 233 1.7× 49 0.5× 97 1.2× 45 0.6× 55 0.9× 28 342

Countries citing papers authored by Loretta D’Onofrio

Since Specialization
Citations

This map shows the geographic impact of Loretta D’Onofrio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loretta D’Onofrio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loretta D’Onofrio more than expected).

Fields of papers citing papers by Loretta D’Onofrio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loretta D’Onofrio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loretta D’Onofrio. The network helps show where Loretta D’Onofrio may publish in the future.

Co-authorship network of co-authors of Loretta D’Onofrio

This figure shows the co-authorship network connecting the top 25 collaborators of Loretta D’Onofrio. A scholar is included among the top collaborators of Loretta D’Onofrio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loretta D’Onofrio. Loretta D’Onofrio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Garrone, Ornella, Tommaso Giarratano, Andrea Michelotti, et al.. (2020). 290P From the CLEOPATRA study to real life: Final results from the G.O.N.O. SUPER trial. Annals of Oncology. 31. S358–S358.
2.
Dell’Aquila, Emanuela, Grazia Armento, Michele Iuliani, et al.. (2020). Denosumab for cancer-related bone loss. Expert Opinion on Biological Therapy. 20(11). 1261–1274. 17 indexed citations
3.
Iodice, Giuseppe, et al.. (2017). Long-term treatment with eribulin in heavily pretreated women with metastatic breast cancer: a case series. Future Oncology. 13(sup11). 25–33. 3 indexed citations
4.
Gamucci, Teresa, Lucia Mentuccia, Isabella Sperduti, et al.. (2017). Efficacy of pertuzumab in combination with trastuzumab and a taxane in first-line treatment for metastatic breast cancer (MBC): A multicenter, retrospective, observational study.. Journal of Clinical Oncology. 35(15_suppl). e12504–e12504. 3 indexed citations
5.
6.
Moscetti, Luca, Patrizia Vici, Isabella Sperduti, et al.. (2015). Safety analysis, correlation with response and previous treatments of the association of everolimus (EVE) and exemestane (EXE) in 181 metastatic breast cancer patients (MBC). Annals of Oncology. 26. vi13–vi13. 1 indexed citations
7.
Vincenzi, Bruno, Loretta D’Onofrio, Anna Maria Frezza, et al.. (2015). Classic Kaposi Sarcoma: to treat or not to treat?. BMC Research Notes. 8(1). 138–138. 10 indexed citations
8.
9.
Santini, Daniele, Chiara Spoto, Loretta D’Onofrio, et al.. (2015). Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence. Breast Cancer Research. 17(1). 121–121. 28 indexed citations
10.
Piredda, Michela, Gabriella Facchinetti, Bruno Vincenzi, et al.. (2015). Propolis for prevention of chemo-induced oral mucositis in breast cancer patients: A randomized controlled trial. Annals of Oncology. 26. vi106–vi106. 2 indexed citations
11.
Russano, Marco, Bruno Vincenzi, Olga Venditti, et al.. (2015). Pazopanib and pancreatic toxicity: a case report. BMC Research Notes. 8(1). 196–196. 7 indexed citations
12.
Barni, Sandro, Caterina Fontanella, Lucia Del Mastro, et al.. (2015). A broad Italian experience with eribulin mesylate in metastatic breast cancer patients: The ESEMPiO study.. Journal of Clinical Oncology. 33(15_suppl). e11539–e11539. 3 indexed citations
13.
Vadacca, Marta, Domenico Paolo Emanuele Margiotta, Luca Navarini, et al.. (2015). SAT0542 Musculoskeletal Syndromes Related to Aromatase Inhibitor Therapy: A Clinical and Laboratory Evaluation. Annals of the Rheumatic Diseases. 74. 856–856.
14.
Imperatori, Marco, et al.. (2015). Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives. SHILAP Revista de lepidopterología. 3(1). 93–99. 8 indexed citations
15.
Vici, Patrizia, Laura Pizzuti, Clara Natoli, et al.. (2014). Triple positive breast cancer: A distinct subtype?. Cancer Treatment Reviews. 41(2). 69–76. 86 indexed citations
16.
D’Onofrio, Loretta, Giuseppe Tonini, & Daniele Santini. (2014). Clinical Features of Male Breast Cancer and Multimodal Treatment: A Comment to Retrospective Survey Analysis at Italian Centers. Tumori Journal. 100(4). e169–e170. 1 indexed citations
17.
Tonini, Giuseppe, Loretta D’Onofrio, Emanuela Dell’Aquila, & Aldo Pezzuto. (2013). New Molecular Insights in Tobacco-Induced Lung Cancer. Future Oncology. 9(5). 649–655. 30 indexed citations
18.
Vincenzi, Bruno, Andrea Napolitano, Loretta D’Onofrio, et al.. (2011). Targeted therapy in sarcomas: mammalian target of rapamycin inhibitors from bench to bedside. Expert Opinion on Investigational Drugs. 20(12). 1685–1705. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wan Ling Tan Breakdown of academic impact, for papers by Aya El Helali Breakdown of academic impact, for papers by Joseph Tang Breakdown of academic impact, for papers by Yunwei Han Breakdown of academic impact, for papers by Shumei Jiang Breakdown of academic impact, for papers by Nikoletta Sidiropoulos Breakdown of academic impact, for papers by Dezuo Dong Breakdown of academic impact, for papers by Giulia Rovesti Breakdown of academic impact, for papers by W. Brückl Breakdown of academic impact, for papers by Kunli Zhu
Rankless by CCL
2026